181 related articles for article (PubMed ID: 9279690)
21. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.
Tamarina NA; McMillan WD; Shively VP; Pearce WH
Surgery; 1997 Aug; 122(2):264-71; discussion 271-2. PubMed ID: 9288131
[TBL] [Abstract][Full Text] [Related]
22. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue.
Kubota T; Nomura T; Takahashi T; Hara K
Arch Oral Biol; 1996 Mar; 41(3):253-62. PubMed ID: 8735011
[TBL] [Abstract][Full Text] [Related]
23. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
Wang M; Fudge K; Rhim JS; Stearns ME
Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
[TBL] [Abstract][Full Text] [Related]
24. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium.
Tyagi SC; Kumar SG; Banks J; Fortson W
J Mol Cell Cardiol; 1995 Oct; 27(10):2177-89. PubMed ID: 8576934
[TBL] [Abstract][Full Text] [Related]
25. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
[TBL] [Abstract][Full Text] [Related]
26. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
27. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.
Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS
Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 beta induction of tissue inhibitor of metalloproteinase (TIMP-1) is functionally antagonized by prostaglandin E2 in human synovial fibroblasts.
DiBattista JA; Pelletier JP; Zafarullah M; Iwata K; Martel-Pelletier J
J Cell Biochem; 1995 Apr; 57(4):619-29. PubMed ID: 7615646
[TBL] [Abstract][Full Text] [Related]
29. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation.
Hampton AL; Salamonsen LA
J Endocrinol; 1994 Apr; 141(1):R1-3. PubMed ID: 8014590
[TBL] [Abstract][Full Text] [Related]
30. Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases.
Colige AC; Lambert CA; Nusgens BV; Lapière CM
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):215-21. PubMed ID: 1637302
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation.
Alexander CM; Hansell EJ; Behrendtsen O; Flannery ML; Kishnani NS; Hawkes SP; Werb Z
Development; 1996 Jun; 122(6):1723-36. PubMed ID: 8674412
[TBL] [Abstract][Full Text] [Related]
32. Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle.
Balcerzak D; Querengesser L; Dixon WT; Baracos VE
J Anim Sci; 2001 Jan; 79(1):94-107. PubMed ID: 11204721
[TBL] [Abstract][Full Text] [Related]
33. Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.
Anderson SS; Wu K; Nagase H; Stettler-Stevenson WG; Kim Y; Tsilibary EC
Cell Adhes Commun; 1996 Aug; 4(2):89-101. PubMed ID: 8937745
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
[TBL] [Abstract][Full Text] [Related]
35. Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts.
Herrmann G; Wlaschek M; Bolsen K; Prenzel K; Goerz G; Scharffetter-Kochanek K
J Invest Dermatol; 1996 Sep; 107(3):398-403. PubMed ID: 8751977
[TBL] [Abstract][Full Text] [Related]
36. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis.
Gomez DE; De Lorenzo MS; Alonso DF; Andrade ZA
Am J Trop Med Hyg; 1999 Jul; 61(1):9-13. PubMed ID: 10432047
[TBL] [Abstract][Full Text] [Related]
37. Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells.
Tyagi SC; Kumar S; Borders S
J Cell Biochem; 1996 Apr; 61(1):139-51. PubMed ID: 8726363
[TBL] [Abstract][Full Text] [Related]
38. RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs.
Pagenstecher A; Stalder AK; Campbell IL
J Immunol Methods; 1997 Aug; 206(1-2):1-9. PubMed ID: 9328562
[TBL] [Abstract][Full Text] [Related]
39. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
Sava G; Capozzi I; Bergamo A; Gagliardi R; Cocchietto M; Masiero L; Onisto M; Alessio E; Mestroni G; Garbisa S
Int J Cancer; 1996 Sep; 68(1):60-6. PubMed ID: 8895542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
